These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 8308316)
21. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus. Mirchamsy H; Nilforoushan MA; Shafyi A; Razavi J; Ashtiani MP; Youssofi I; Sassani A; Fateh G; Nassiri S Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112 [TBL] [Abstract][Full Text] [Related]
22. Responses to measles immunization in children infected with human immunodeficiency virus. Rudy BJ; Rutstein RM; Pinto-Martin J J Pediatr; 1994 Jul; 125(1):72-4. PubMed ID: 8021790 [TBL] [Abstract][Full Text] [Related]
23. Response to measles-mumps-rubella vaccine in children on dialysis. Schulman SL; Deforest A; Kaiser BA; Polinsky MS; Baluarte HJ Pediatr Nephrol; 1992 Mar; 6(2):187-9. PubMed ID: 1571219 [TBL] [Abstract][Full Text] [Related]
24. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Davidkin I; Peltola H; Leinikki P; Valle M Vaccine; 2000 Jul; 18(27):3106-12. PubMed ID: 10856790 [TBL] [Abstract][Full Text] [Related]
25. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination. Matter L; Germann D; Bally F; Schopfer K Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781 [TBL] [Abstract][Full Text] [Related]
26. [Responses to triple viral and tetanus vaccination in HIV-infected children]. Echeverría Lecuona J; Aldamiz-Echevarría Azuara L; Cilla Eguiluz G; Pérez Trallero E An Esp Pediatr; 1996 Apr; 44(4):317-20. PubMed ID: 8849078 [TBL] [Abstract][Full Text] [Related]
27. Determination of measles, mumps, and rubella immunization status using oral fluid samples. Thieme T; Piacentini S; Davidson S; Steingart K JAMA; 1994 Jul; 272(3):219-21. PubMed ID: 8022041 [TBL] [Abstract][Full Text] [Related]
28. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children. Watson BM; Laufer DS; Kuter BJ; Staehle B; White CJ; Starr SE J Infect Dis; 1996 Mar; 173(3):731-4. PubMed ID: 8627041 [TBL] [Abstract][Full Text] [Related]
29. Serological evaluation of a measles, mumps, and rubella vaccine. Robertson CM; Bennett VJ; Jefferson N; Mayon-White RT Arch Dis Child; 1988 Jun; 63(6):612-6. PubMed ID: 3291787 [TBL] [Abstract][Full Text] [Related]
30. Low mumps antibody levels induced by mumps-measles-rubella vaccinations in type 1 diabetic children. Hiltunen M; Hyöty H; Leinikki P; Akerblom HK; Tuomilehto J; Vesikari T Diabet Med; 1994 Dec; 11(10):942-6. PubMed ID: 7895458 [TBL] [Abstract][Full Text] [Related]
31. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination. Should we be concerned? Watada B; Kennedy K; Chan D; Church B; Patriquin M; Shariff F; Evans MF Can Fam Physician; 1998 Jan; 44():53-5. PubMed ID: 9481462 [No Abstract] [Full Text] [Related]
32. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study]. He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468 [No Abstract] [Full Text] [Related]
33. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine. André FE; Peetermans J Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells. Just M; Berger R; Glück R; Wegmann A Dev Biol Stand; 1986; 65():25-7. PubMed ID: 3549399 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response. Nakayama T; Urano T; Osano M; Nakagawa M; Maehara N; Sasaki K; Yamamura AM; Makino S Microbiol Immunol; 1990; 34(6):497-508. PubMed ID: 2120551 [TBL] [Abstract][Full Text] [Related]
36. Immunity to measles and rubella in women infected with human immunodeficiency virus. Clark RA; Dlamini G; Brandon W; Wisniewski T Clin Infect Dis; 1992 Oct; 15(4):739. PubMed ID: 1420696 [No Abstract] [Full Text] [Related]
37. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection. Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672 [TBL] [Abstract][Full Text] [Related]
38. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds. Krober MS; Stracener CE; Bass JW JAMA; 1991 Apr; 265(16):2095-6. PubMed ID: 2013930 [TBL] [Abstract][Full Text] [Related]
39. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old]. Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251 [TBL] [Abstract][Full Text] [Related]
40. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children. Kanesaki T; Baba K; Tsuda N; Yabuuchi H; Yamanishi K; Takahashi M Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]